How China plans to โfirmly rank at the global forefrontโ with 25% of first-in-class drugs
China has set its sights on becoming a global biomedicine powerhouse by 2030, targeting key technological breakthroughs and at least a quarter of the worldโs first-in-class drugs market under a new five-year plan for the sector. By the end of the decade, China would โfirmly rank at the global forefrontโ in biopharmaceutical research and development and applications, with its โcore competitivenessโ and international influence making a significant leap, authorities said on Friday. The biomedical...